Partners
RegMed XB is a collaboration of parties with the best interest of patients at heart. Each partner performs excellent science or is working on commercializing Regenerative Medicine (RM) technologies: health foundations, scientists, entrepreneurs, and (local) governments. Cooperatively these partners tackle ambitious challenges in regenerative medicine.
The established collaboration with and of these partners creates a pool of multidisciplinary knowledge that is required to bring RM to society. Together, we are passionate about building a mature RM industry and have a societal impact by bringing these solutions to patients as quickly as possible. And together we aim to radically change the lives of patients: cure their disease!
Crossing Borders
In October 2024 RegMed XB and Nakanoshima Qross (International Hub for Future Medicine) in Osaka, Japan, signed a memorandum of understanding to promote cooperation in the field of regenerative medicine.
In July 2025, RegMed XB and Inserm—a public scientific and technological institute operating under the joint authority of the French Ministries of Health and Research—signed a memorandum of understanding, paving the way for intensified collaboration in the field of regenerative medicine.
-
RegMed XB's Ecosystem
Health Foundations
The following Dutch health foundations are involved in defining research objectives and provide guidance in the research we conduct to ensure we maintain focus on the patient.
read moreAcademic Partners
RegMed XB works together with (inter)national top-rated academic institutions and collaborates specifically and exclusively with researchers who contribute specific expertise to the Moonshot initiatives.
read moreIndustrial Partners
Partnering with companies offers access to their expertise in designing scalable and feasible products. Currently, we have strong partnerships with the following entities.
read moreGovernmental Partners
RegMed XB receives support from national and local governments to de-risk promising concepts from academia to proof of concept or initial clinical trial stages.
read more